202 related articles for article (PubMed ID: 30557822)
1. Donor T-cell-derived interleukin-22 promotes thymus regeneration and alleviates chronic graft-versus-host disease in murine allogeneic hematopoietic cell transplant.
Pan B; Zhang F; Lu Z; Li L; Shang L; Xia F; Fu R; Xu M; Zeng L; Xu K
Int Immunopharmacol; 2019 Feb; 67():194-201. PubMed ID: 30557822
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
[TBL] [Abstract][Full Text] [Related]
3. IL-22 Accelerates Thymus Regeneration via Stat3/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants.
Pan B; Wang D; Li L; Shang L; Xia F; Zhang F; Zhang Y; Gale RP; Xu M; Li Z; Xu K
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1911-1919. PubMed ID: 31195136
[TBL] [Abstract][Full Text] [Related]
4. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
Dudakov JA; Mertelsmann AM; O'Connor MH; Jenq RR; Velardi E; Young LF; Smith OM; Boyd RL; van den Brink MRM; Hanash AM
Blood; 2017 Aug; 130(7):933-942. PubMed ID: 28607133
[TBL] [Abstract][Full Text] [Related]
5. [The role of IL-22 on thymus recovery and its function in mice following allogeneic bone marrow transplantation].
Zhao K; Zhao D; Yin L; Pan B; Xu K
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):822-5. PubMed ID: 25246251
[TBL] [Abstract][Full Text] [Related]
6. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
7. Recipient-derived IL-22 alleviates murine acute graft-versus-host disease in association with reduced activation of antigen presenting cells.
Pan B; Xia F; Wu Y; Zhang F; Lu Z; Fu R; Shang L; Li L; Sun Z; Zeng L; Xu K
Cytokine; 2018 Nov; 111():33-40. PubMed ID: 30114627
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.
Wang Y; Chen G; Qiao S; Ma X; Tang X; Sun A; Wu D
Leuk Lymphoma; 2011 Aug; 52(8):1556-66. PubMed ID: 21649545
[TBL] [Abstract][Full Text] [Related]
9. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
Toubert A; Glauzy S; Douay C; Clave E
Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Thymic Repair of In Vitro-Induced Precursor T Cells as a Haploidentical Hematopoietic Stem Cell Transplantation Regimen.
Lei YY; Chen XR; Jiang S; Guo M; Yu CL; Qiao JH; Cai B; Ai HS; Wang Y; Hu KX
Transplant Cell Ther; 2023 Jun; 29(6):382.e1-382.e11. PubMed ID: 36944387
[TBL] [Abstract][Full Text] [Related]
11. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.
Toubai T; Tamaki H; Peltier DC; Rossi C; Oravecz-Wilson K; Liu C; Zajac C; Wu J; Sun Y; Fujiwara H; Henig I; Kim S; Lombard DB; Reddy P
J Immunol; 2018 Dec; 201(11):3443-3455. PubMed ID: 30389773
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
[TBL] [Abstract][Full Text] [Related]
15. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
16. Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation.
Lai L; Cui C; Jin J; Hao Z; Zheng Q; Ying M; Boyd R; Zhao Y
Blood; 2011 Sep; 118(12):3410-8. PubMed ID: 21791423
[TBL] [Abstract][Full Text] [Related]
17. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation.
Imado T; Iwasaki T; Kataoka Y; Kuroiwa T; Hara H; Fujimoto J; Sano H
Blood; 2004 Sep; 104(5):1542-9. PubMed ID: 15100150
[TBL] [Abstract][Full Text] [Related]
19. Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant.
McIver Z; Melenhorst JJ; Wu C; Grim A; Ito S; Cho I; Hensel N; Battiwalla M; Barrett AJ
Haematologica; 2013 Mar; 98(3):346-52. PubMed ID: 23065508
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation.
Goldberg GL; Alpdogan O; Muriglan SJ; Hammett MV; Milton MK; Eng JM; Hubbard VM; Kochman A; Willis LM; Greenberg AS; Tjoe KH; Sutherland JS; Chidgey A; van den Brink MR; Boyd RL
J Immunol; 2007 Jun; 178(11):7473-84. PubMed ID: 17513799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
